Axcelis Technologies, Inc. (NASDAQ:ACLS) Receives Average Rating of "Hold" from Brokerages

Key Points

• Axcelis Technologies has a consensus “Hold” rating from seven analysts: three rate it a buy, three a hold, and one a sell. The average 12-month price target is $132.20.
• Recent analyst actions were mixed: Craig Hallum downgraded the stock to “Hold” with a $140 target, while Bank of America raised its target to $156 but maintained an “Underperform” rating.
• Axcelis exceeded quarterly expectations, reporting $1.06 in EPS versus the $0.89 consensus and $215.18 million in revenue versus $205.03 million expected. Shares opened at $115.56, down 3%, while institutional investors own nearly 90% of the stock.

Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Get Free Report) have been assigned a consensus rating of "Hold" from the seven research firms that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $132.20.

Several brokerages recently weighed in on ACLS. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Axcelis Technologies in a research note on Friday, August 7th. Craig Hallum cut shares of Axcelis Technologies from a "buy" rating to a "hold" rating and set a $140.00 target price on the stock. in a report on Friday, August 7th. Finally, Bank of America upped their target price on shares of Axcelis Technologies from $130.00 to $156.00 and gave the stock an "underperform" rating in a research report on Tuesday, June 23rd.

Axcelis Technologies Stock Down 3.0%

Shares of Axcelis Technologies stock opened at $115.56 on Thursday. The company has a current ratio of 4.90, a quick ratio of 3.21 and a debt-to-equity ratio of 0.04. Axcelis Technologies has a 12-month low of $73.60 and a 12-month high of $193.78. The company has a market cap of $3.57 billion, a P/E ratio of 38.78, a PEG ratio of 3.64 and a beta of 1.86. The company's fifty day simple moving average is $130.89 and its two-hundred day simple moving average is $130.31.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last posted its earnings results on Thursday, August 6th. The semiconductor company reported $1.06 EPS for the quarter, topping the consensus estimate of $0.89 by $0.17. The firm had revenue of $215.18 million during the quarter, compared to analysts' expectations of $205.03 million. Axcelis Technologies had a net margin of 10.71% and a return on equity of 11.69%. The company's quarterly revenue was up 10.6% compared to the same quarter last year. During the same period last year, the company posted $1.13 EPS. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. Research analysts anticipate that Axcelis Technologies will post 3.39 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. REAP Financial Group LLC bought a new stake in Axcelis Technologies in the fourth quarter worth $25,000. Advisory Services Network LLC bought a new position in shares of Axcelis Technologies during the third quarter valued at $32,000. Public Employees Retirement System of Ohio bought a new position in shares of Axcelis Technologies during the second quarter valued at $82,000. EverSource Wealth Advisors LLC raised its position in shares of Axcelis Technologies by 145.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 451 shares of the semiconductor company's stock worth $31,000 after purchasing an additional 267 shares during the last quarter. Finally, Leonteq Securities AG bought a new position in Axcelis Technologies in the 4th quarter worth about $40,000. Institutional investors own 89.98% of the company's stock.

About Axcelis Technologies

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company's product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.